Breathing Training and Exercise Capacity in Non-CFB

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21-80
SponsorMayo Clinic

About this trial

The purpose of this research is to investigate whether a home-based and health coach supported specific breathing and respiratory muscle training program improves the ability to exercise, the function of the lungs and breathing muscles, and general clinical status in people with non-cystic fibrosis bronchiectasis (non-CFB).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Mayo Clinic patient with confirmed diagnosis of Non-Cystic Fibrosis Bronchiectasis (non-CFB): Non-CFB as confirmed by clinical history, including cough, shortness of breath, exertional dyspnea, pulmonary function tests, and high-resolution computed tomography. Patients will be considered clinically stable if there is no evidence of an exacerbation or change(s) in medical therapy in the previous three weeks.

Able and willing to provide informed consent to participate in the study.

Disqualifiers

Presence of significant coexisting disease, neurological conditions, and/or orthopedic complications that affect ability to undertake exercise.

Presence of advanced heart failure.

Current use of antibiotics.

Acute exacerbation(s) within 3-weeks prior to study commencement.

Trial design

Design model

Parallel

Treatments tested in this trial

  • LungTrainers

    Device

    A training device that provides a variable resistance against which users breathe out. Users breathe through a plastic mouthpiece that is connected to an acrylic cylinder via rubber tubing. The mouthpiece has several small holes of various diameters and up to three stainless steel weights (half-weight increments) can be inserted into the acrylic tube. With each breath-out, the user exhales against the resistance provided by the weight inserts, and each inspiration (i.e., breath-in) is unresisted. During each resisted exhalation, the weight inserts are 'lifted' within the acrylic tube depending on the level of expiratory pressure generated by the participant.

  • LungTrainers Pulmonary Rehabilitation regime

    Behavioral

    Series of different exercises using the LungTrainers device 3-5 days per week for approximately 10 weeks. Exercises complete in one long session (20-30 minutes) or be broken down into multiple shorter sessions (e.g., 3 x 10 minutes). A health coach will be assigned to guide participants through the LT-PR program.

Treatment groups

50 Participants
are divided into 2 treatment groups
Group A: Control group of standard physician directed careNo intervention 0 interventions
Group B: Home-based specific breathing and respiratory muscle training groupExperimental treatment 2 interventions

Trial outcomes

Primary outcomes

1

Change in six-minute walk test distance

Measures the distance walked in meters for 6 minutes.

Time frame
Baseline, 8 weeks
2

Change in peak oxygen uptake during maximal incremental exercise test

Maximum volume or amount of oxygen consumption during cardiopulmonary exercise test (treadmill or cycle).

Time frame
Baseline, 8 weeks

Secondary outcomes

1

Change in exercise time during maximal incremental exercise test

Maximum volume or amount of oxygen consumption during cardiopulmonary exercise test (treadmill or cycle).

Time frame
Baseline, 8 weeks
2

Peak exercise work rate during maximal incremental exercise test

Highest work rate achieved during cardiopulmonary exercise test (treadmill or cycle)

Time frame
Baseline, 8 weeks
3

Change in forced vital capacity

Measured by spirometry to determine the maximal amount of air that can be forcibly exhaled from the lungs after a full inhale, reported as liters (L).

Time frame
Baseline, 8 weeks
4

Change in forced expiratory volume in 1 second

Measured by spirometry to determine the volume of air that can be exhaled in 1 second with a forced breath.

Time frame
Baseline, 8 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.